Analyst Reports

Analyst: Chhai Ung

This report has been commissioned and paid for by Actinogen Medical Limited (Company) and has been prepared by Red Leaf Securities, an Authorised Representative of BR Securities. The report solely reflects the views of Red Leaf Securities.

Any opinions, forecasts, recommendations or forward looking statements in the report reflect the judgement and assumptions of Red Leaf Securities at the date of publication of the report. The Company does not endorse the findings or contents of the report, including any price target, earnings forecast or other statement about the Company’s prospects, and will not be responsible for any loss or damage arising in any way from errors, omissions or misstatements in the report or the use of, or reliance on, the report in any way.

Continue to report

This report has been commissioned and paid for by Actinogen Medical Limited (Company) and has been prepared by Red Leaf Securities, an Authorised Representative of BR Securities. The report solely reflects the views of Red Leaf Securities.

Any opinions, forecasts, recommendations or forward looking statements in the report reflect the judgement and assumptions of Red Leaf Securities at the date of publication of the report. The Company does not endorse the findings or contents of the report, including any price target, earnings forecast or other statement about the Company’s prospects, and will not be responsible for any loss or damage arising in any way from errors, omissions or misstatements in the report or the use of, or reliance on, the report in any way.

Continue to report

Analyst: Stuart Roberts

This report has been commissioned and paid for by Actinogen Medical Limited (Company) and has been prepared by NDF Research, an Authorised Representative of BR Securities Australia Pty Ltd. The report solely reflects the views of NDF Research.

Any opinions, forecasts, recommendations or forward looking statements in the report reflect the judgement and assumptions of NDF Research at the date of publication of the report. The Company does not endorse the findings or contents of the report, including any price target, earnings forecast or other statement about the Company’s prospects, and will not be responsible for any loss or damage arising in any way from errors, omissions or misstatements in the report or the use of, or reliance on, the report in any way.

Continue to report